Home Search

translational research - search results

If you're not happy with the results, please do another search
treatments for heart failure,

Innovative treatments for heart failure

Prof Dr Joost Sluijter, Professor, Cellular and Translational Cardiology at University Medical Center Utrecht shares an in-depth perspective on the needs for innovative treatments for heart failure.
pancreatic cancer patients, new drug

New drug offers promising treatment for pancreatic cancer patients

Scientists have invented a new drug which could improve life expectancy and quality for patients with hard-to-treat cancers, such as pancreatic cancer.
contracting COVID-19

Study suggests that asthma does not increase the severity of COVID-19

According to a team of Rutgers researchers, asthma does not appear to increase the risk or severity for a person contracting COVID-19.
Dr Oliver Planz

Dr Oliver Planz, PhD – Eberhard Karls Universit

Oliver Planz is Professor for Immunology and Cell Biology and heads the group “Translational Immunology of Infection” in the Department of Immunology at the University of Tuebingen. He is an expert in antiviral research and translational preclinical R&D up to clinical studies and CSO for Atriva Therapeutics GmbH.
global learning health system

Enabling a global learning health system through genomic standards

Peter Goodhand and Angela Page from Global Alliance for Genomics and Health, explain their thoughts on enabling a global learning health system through genomic standards.
understand brain function, elementary navigation

Turning left, right or going straight: Using elementary navigation decisions to understand brain function

Dr Stanley Heinze, Associate Professor at Lund University’s Department of Biology, underlines his work on neuroscience, notably using elementary navigation decisions to understand brain function.
national toxicology program

The National Toxicology Program: Needs and opportunities

Open Access Government spoke to Dr Brian Berridge, Associate Director of the National Toxicology Program (NTP) in the U.S., about the needs and opportunities he sees within the NTP.
neurodegenerative diseases, protein

A brief overview of advances in neurodegenerative diseases

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, provides an overview of Neurodegenerative Diseases.
biomarkers for oncology,Proteomics

Cancer: Breakthrough technologies allowing leveraging biomarkers for oncology

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, provides a cancer focus, in particular, she details breakthrough technologies that allow leveraging biomarkers for oncology.
remote diagnostic procedure over 5G

UK see’s first remote diagnostic procedure over 5G

BT and the University Hospital Birmingham have demonstrated the UK’s first remote diagnostic procedure over 5G.
Distributive biobanking models

Distributive biobanking models: Why biospecimens need blockchain

Here, several experts from the International Society for Biological and Environmental Repositories provide a novel perspective around distributive biobanking models, including why biospecimens need blockchain.
noisy environments, hearing speech

Hearing speech in noisy environments

PhD students Courtney Coburn Glavin, Kailyn A. McFarlane, and Assistant Professor Jason Tait Sanchez discuss the mechanisms, barriers, and future progress for hearing speech in noisy environments.
vessel growth

Vessel growth in health and disease

John Greenwood PhD FRCPath and Stephen E. Moss PhD from UCL Institute of Ophthalmology discuss the vasculature in health and disease, a major focus of their research.
brain disorders in europe, european brain council

Tackling the growing burden of brain disorders in Europe

Frédéric Destrebecq, Executive Director of the European Brain Council explains the importance of tackling the growing burden of brain disorders in Europe.

Making chemistry matter: The value of discovery

Prof Colin J Suckling OBE DSc FRSE from the Department of Pure & Applied Chemistry, at University of Strathclyde, explains the value of discovery when it comes to making chemistry matter.
archaeology of collagen

Chemistry and the archaeology of collagen

Takashi Nakazawa, Professor at Nara Women’s University explores some fascinating aspects of chemistry and the archaeology of collagen, as well as a view point expressed on analysing ancient specimens in a collaborative way.
patient information

Key patient information stored in routinely collected healthcare free-text data is still untapped

Goran Nenadic, from The University of Manchester and The Alan Turing Institute, argues for using patient information stored in routinely collected healthcare free-text data.
drug monitoring in cancer

Point-of-care devices for therapeutic drug monitoring in cancer treatment and beyond

DiaChemo is a European project developing a platform technology for point-of-care devices for therapeutic drug monitoring in cancer treatment and beyond, reveals Dr Silke Krol, Head of the Translational Nanotechnology Lab and Coordinator of the DIACHEMO Project.
therapeutic drug monitoring

Point-of-care devices technology for therapeutic drug monitoring in cancer treatment and beyond

Christian Siebel and Dott.ssa Bianca Posocco detail the work of DIACHEMO, a Euroepan project developing a platform technology for point-of-care devices for chemotherapeutics and other drugs.
neurodegenerative disorders

Treatment and diagnosis of neurodegenerative disorders

Andrea Varrone studies the importance of molecular imaging to provide personalised medicine and improve care for patients with neurodegenerative disorders

Follow Us

Advertisements